The global robotic surgery market is experiencing rapid growth, with its size expanding from USD 11.83 billion in 2024 to an expected USD 54.66 billion by 2034, growing at a CAGR of 16.54%. This surge is driven by the rising prevalence of chronic diseases and increasing preference for minimally invasive surgeries worldwide. North America currently leads the market, while Asia Pacific is anticipated to exhibit the fastest growth. The market is primarily dominated by product offerings, with services expected to grow swiftly, and key applications include orthopedics and general surgery. Hospitals remain the primary end-users, though ambulatory surgical centers are growing quickly.
Download the free sample and get the full report for complete insights and forecasts on this market @ https://www.towardshealthcare.com/download-sample/5502
Headquarters: Sunnyvale, California, USA
Strengths:
◉Pioneer and global leader in robotic-assisted surgery systems.
◉Extensive installed base with over 7,000 da Vinci Surgical Systems worldwide.
◉Strong brand recognition and surgeon trust.
◉Large ecosystem of instruments and accessories.
Key Products:
◉da Vinci Surgical System (various models: Xi, X, SP)
◉Ion Endoluminal System (for lung biopsy)
◉EndoWrist instruments and accessories
Notes: Continues to invest heavily in R&D and training, holding a dominant market share globally.
Headquarters: Kalamazoo, Michigan, USA
Strengths:
◉Leader in orthopedic surgical robotics.
◉Strong integration of robotics with its orthopedic implant and surgical equipment portfolio.
◉High adoption in hospitals worldwide.
Key Products:
◉MAKO Robotic-Arm Assisted Surgery System (for knee, hip replacements)
◉NAV3 Surgical Navigation Platform
Notes: Growing focus on expanding robotic solutions beyond orthopedics.
Headquarters: Dublin, Ireland
Strengths:
◉One of the largest medical technology companies globally.
◉Strong focus on minimally invasive robotic surgery platforms.
◉Broad portfolio spanning neurosurgery, spine, and general surgery.
Key Products:
◉Hugo robotic-assisted surgery system (collaboration with Verily)
◉Mazor X Stealth Edition (spinal surgery robotics)
Notes: Leveraging data and AI to enhance robotic surgical precision.
Headquarters: New Brunswick, New Jersey, USA
Strengths:
◉Massive healthcare presence and R&D capabilities.
◉Recent entry into robotic surgery with strong financial backing.
◉Focus on integrating robotic systems with advanced surgical devices.
Key Products:
◉Ottava Robotic Surgical System (under development in partnership with Verb Surgical)
Notes: Expected to disrupt the market with comprehensive robotic surgical solutions.
Headquarters: London, United Kingdom
Strengths:
◉Strong presence in orthopedic surgery and sports medicine.
◉Focus on robotic-assisted joint replacement systems.
Key Products:
◉CORI Surgical System (robotic-assisted platform for knee and hip surgery)
Notes: Known for compact, portable robotic systems emphasizing surgeon control.
Headquarters: Warsaw, Indiana, USA
Strengths:
◉Established orthopedic implant and surgical device manufacturer.
◉Growing focus on robotic and navigation-assisted surgery.
Key Products:
◉ROSA Knee System (robotic-assisted knee replacement)
◉ROSA Brain System (robotic neurosurgery)
Notes: Strong integration between implants and robotic assistance for improved outcomes.
Headquarters: Durham, North Carolina, USA
Strengths:
◉Innovator in digital laparoscopy and robotic surgical platforms.
◉Focus on AI and augmented intelligence in surgery.
Key Products:
◉Senhance Surgical System (robotic digital laparoscope system)
Notes: Growing adoption in ambulatory and community hospitals.
Headquarters: Tokyo, Japan
Strengths:
◉Strong legacy in endoscopic imaging and minimally invasive surgery.
◉Integration of robotics with endoscopy and surgical visualization.
Key Products:
◉ENDOEYE 3D System
◉Robotic-assisted endoscopic tools (in development)
Notes: Focus on enhancing image-guided robotic surgery.
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5502
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
The global multiple myeloma market was valued at approximately USD 27.75 billion in 2024 and is expected to grow steadily… Read More
The global medical devices market is experiencing robust growth, valued at approximately USD 551.3 billion in 2024 and expected to… Read More
The global breast implants market was valued at approximately USD 2.72 billion in 2024 and is projected to grow to… Read More
The global nutraceuticals market is experiencing robust growth, valued at USD 591.15 billion in 2024 and projected to more than… Read More
The global robotic surgery market is rapidly expanding, valued at USD 11.83 billion in 2024 and expected to reach approximately… Read More
The global multiple myeloma market was valued at approximately USD 27.75 billion in 2024 and is expected to grow to… Read More